When chronic lymphocytic leukemia suddenly changes into a more aggressive form of cancer, this transformation is called Richter’s syndrome. Recognizing the warning signs early and getting the right tests done can help doctors make the correct diagnosis and start appropriate treatment as soon as possible.

Introduction: Who Needs Testing for Richter’s Syndrome

Richter’s syndrome is a rare but serious complication that can develop in people who have been diagnosed with chronic lymphocytic leukemia, commonly known as CLL. This transformation occurs when CLL suddenly changes into a much more aggressive type of cancer, most often a fast-growing lymphoma called diffuse large B-cell lymphoma.^[2] Because this change can happen quickly and make someone quite ill in a short time, knowing when to seek diagnostic testing is essential.

Anyone who has been diagnosed with CLL should be aware of the possibility of Richter’s syndrome, though it remains relatively uncommon. Studies show that between 2 and 10 out of every 100 people with CLL will develop this transformation during their lifetime, with a yearly transformation rate of about 0.5 to 1 percent.^[2][20] This means that while most people with CLL will never experience this transformation, it’s important for both patients and their doctors to stay alert to warning signs.

The timing of when Richter’s syndrome might develop varies greatly from person to person. It can appear at any point during the course of CLL, whether someone has had the disease for just a few months or many years.^[5] In some unusual cases, doctors have diagnosed Richter’s syndrome in people who didn’t even know they had underlying CLL, discovering both conditions at the same time.^[2]

You should seek diagnostic evaluation if you notice certain warning signs, especially if they develop suddenly or worsen dramatically. The most common reason people contact their doctor is the rapid appearance or growth of swollen lymph nodes, particularly in the neck, armpit, groin, or abdomen.^[2][5] Other concerning symptoms include persistent fever that isn’t caused by an infection, drenching night sweats that soak through your clothes or bedding, unexplained weight loss, or discomfort in your belly caused by an enlarged spleen.^[17]

What makes these symptoms particularly worrisome is how quickly they can appear. Unlike the gradual progression often seen with CLL alone, Richter’s syndrome can cause someone to become quite unwell within days or weeks.^[2] This rapid change in your health status is a critical signal that you need medical attention right away.

Diagnostic Methods for Identifying Richter’s Syndrome

When a doctor suspects that CLL might have transformed into Richter’s syndrome, several diagnostic tests are needed to confirm the diagnosis and understand what type of cancer has developed. The process usually begins with a physical examination and progresses to more specialized testing.

Physical Examination and Initial Assessment

Your doctor will start by examining you thoroughly, paying special attention to areas where lymph nodes are located, such as your neck, armpits, and groin. They will feel for any enlarged lymph nodes and note their size, texture, and whether they’ve grown quickly. The doctor will also check your abdomen to see if your liver or spleen feels larger than normal.^[3] During this examination, they’ll ask detailed questions about when your symptoms started and how rapidly they’ve progressed.

Blood Tests

Blood tests play an important role in the diagnostic process. Your healthcare team will draw blood to check various markers that can suggest transformation has occurred. One important test looks at lactate dehydrogenase, or LDH, which is an enzyme that often increases dramatically when Richter’s syndrome develops.^[4] Elevated LDH levels can be a red flag that warrants further investigation. Your doctor may also check calcium levels in your blood, as high calcium, called hypercalcemia, can sometimes occur with this condition.^[4]

Additional blood work will include a complete blood count to check your red blood cells, white blood cells, and platelets. Low platelet levels might be discovered, which can cause problems with bleeding or bruising.^[4] These blood tests provide important clues but cannot definitively diagnose Richter’s syndrome on their own.

PET-CT Scan

One of the most valuable tools for diagnosing Richter’s syndrome is a special type of scan called a PET-CT scan, which stands for positron emission tomography combined with computed tomography. This imaging test uses a small amount of radioactive sugar that is injected into your vein before the scan. Cancer cells tend to absorb more of this sugar than normal cells, causing them to light up on the scan.^[5]

The PET-CT scan is particularly useful because it can show which lymph nodes are most active and aggressive. The scan measures something called standardized uptake value, or SUV, which indicates how much radioactive sugar a particular area has absorbed. Higher SUV values suggest more aggressive disease.^[3] This information helps your doctor decide which lymph node should be biopsied, as choosing the right one increases the chances of getting an accurate diagnosis.

Lymph Node Biopsy

The gold standard for diagnosing Richter’s syndrome is a lymph node biopsy. This procedure involves removing part or all of an enlarged lymph node so it can be examined under a microscope by a specialist called a pathologist.^[2][17] The biopsy is essential because it allows doctors to see exactly what type of cells are present and whether CLL has indeed transformed into a more aggressive lymphoma.

There are different types of biopsies, but for suspected Richter’s syndrome, doctors strongly prefer an excisional biopsy, which means removing an entire lymph node rather than just taking a small sample. This provides the most tissue for examination and gives the best chance of accurate diagnosis.^[5] The procedure is typically done in an operating room under local or general anesthesia, depending on the location of the lymph node.

Sometimes doctors may first try a needle biopsy, where a needle is inserted into the lymph node to remove a small sample. However, this method can sometimes miss the transformed cells because they may not be evenly distributed throughout the node.^[3] When the PET-CT scan has identified which lymph node looks most suspicious, the doctor will target that one for biopsy to maximize the chances of finding the transformed cells.

Once the tissue sample reaches the laboratory, the pathologist examines it carefully under a microscope. They look for specific features that distinguish Richter’s syndrome from regular CLL. In Richter’s syndrome, instead of seeing small, uniform lymphocytes typical of CLL, the pathologist will observe larger, more abnormal cells with features suggesting aggressive lymphoma.^[3] The most common finding is diffuse large B-cell lymphoma, which accounts for about 90 out of 100 cases of Richter’s syndrome.^[2]

In rare cases, about 10 out of 100 times, CLL transforms into Hodgkin lymphoma instead of diffuse large B-cell lymphoma.^[2] The pathologist can tell these two types apart by looking at the specific characteristics of the cells and using special staining techniques. This distinction is important because the two types may require different treatment approaches.

Bone Marrow Biopsy

In some cases, your doctor may also recommend a bone marrow biopsy, where a sample of bone marrow is taken, usually from your hip bone. This test helps determine whether the transformed lymphoma has spread to the bone marrow, which can affect treatment decisions.^[17] The procedure is done using a special needle to withdraw a small amount of liquid bone marrow and sometimes a tiny core of bone tissue. While it can be uncomfortable, local anesthesia helps minimize pain during the procedure.

Immunohistochemistry and Flow Cytometry

Beyond just looking at cells under a microscope, additional specialized tests are performed on the biopsy samples. Immunohistochemistry uses special antibodies that stick to specific proteins on the surface of cells. This helps identify exactly what type of lymphoma cells are present.^[3] For example, in CLL, cells typically test positive for markers called CD5 and CD23, but transformed cells may have different marker patterns.

These molecular tests help doctors understand not just that transformation has occurred, but also the specific characteristics of the transformed cells. This information guides treatment decisions and helps predict how the disease might behave.

Additional Imaging Studies

Beyond the PET-CT scan, other imaging tests may be ordered to get a complete picture of the disease. Regular CT scans of the chest, abdomen, and pelvis can show the size and location of enlarged lymph nodes and organs. Ultrasound might be used to examine specific areas, such as the abdomen, to check for an enlarged spleen or liver.^[3] These imaging studies help doctors understand how widespread the disease is, which is important for planning treatment.

Diagnostic Testing for Clinical Trial Enrollment

For patients who are considering joining a clinical trial to test new treatments for Richter’s syndrome, additional diagnostic tests may be required beyond those used for standard diagnosis. Clinical trials use specific criteria to determine which patients can participate, ensuring the study results are meaningful and that participants receive appropriate care.

Baseline Assessment Requirements

Before enrolling in a clinical trial, patients typically undergo comprehensive baseline testing to document the extent of their disease. This usually includes all the standard diagnostic tests mentioned earlier: physical examination, blood work, PET-CT scanning, and confirmed biopsy results showing transformation to aggressive lymphoma.^[14] These baseline measurements establish a starting point against which the effectiveness of the experimental treatment can be measured.

Genetic and Molecular Testing

Clinical trials often require detailed genetic analysis of the cancer cells. Special tests look for specific mutations, which are changes in the genes of cancer cells that can affect how the disease behaves and responds to treatment. For example, trials may test for changes in genes called TP53, NOTCH1, or CDKN2A, which are known to play roles in Richter’s syndrome.^[9]

Some studies specifically look for whether the transformed lymphoma cells are related to the original CLL cells or represent a completely new cancer. This is important because about 80 out of 100 cases of Richter’s syndrome are clonally related to the original CLL, meaning they evolved from the CLL cells.^[20] The remaining 20 percent represent an entirely new, unrelated lymphoma that happened to develop in someone who also has CLL. These two situations have different prognoses and may respond differently to treatment, so clinical trials often want to know which type a patient has.

Organ Function Tests

Clinical trials require evidence that major organs are functioning well enough to handle the experimental treatment. This means additional blood tests to check kidney function, liver function, and heart health. You may need an electrocardiogram, or EKG, to check your heart rhythm, or an echocardiogram, which uses sound waves to create pictures of your heart in motion.^[19] These tests ensure it’s safe for you to receive the study treatment.

Performance Status Assessment

Clinical trials also evaluate your overall health and ability to carry out daily activities, often using standardized scales. This helps researchers ensure that participants are well enough to potentially benefit from the experimental treatment and complete the study. Your doctor will ask about your energy level, ability to work, and whether you need help with basic self-care activities.

Special Imaging for Treatment Response

Many clinical trials use PET-CT scans not just for initial diagnosis but also to measure how well the treatment is working. Scans may be repeated at specific intervals during and after treatment to see if the cancer is shrinking or if the SUV values are decreasing, which would suggest the treatment is effective.^[5] Having baseline scans done according to specific protocols ensures accurate comparison as treatment progresses.

Biomarker Studies

Some clinical trials collect blood, tissue, or bone marrow samples for research purposes, looking for biomarkers that might predict which patients will respond best to particular treatments. These samples may be analyzed for levels of specific proteins, the presence of circulating tumor cells, or other biological features. While these research tests don’t affect your immediate care, they help scientists better understand Richter’s syndrome and develop improved treatments for future patients.^[9]

Documentation and Eligibility Criteria

Clinical trials have very specific requirements about what tests need to be done and how recently they must have been performed. For example, a trial might require that your biopsy was done within the past three months, or that certain blood tests are no more than two weeks old. These strict timelines ensure that your test results accurately reflect your current health status when you begin the experimental treatment.

Each clinical trial has its own unique set of eligibility criteria, which are the rules about who can and cannot participate. Some trials may require that you haven’t received certain previous treatments, while others might specifically look for patients who have already tried standard therapies. Your medical team will help determine which trials you might qualify for based on your diagnostic test results and medical history.